Multiprofile Hospital for Active Treatment - Haskovo

Haskovo 6300

0 studies enrolling now · 3 studies all time

What they study most

Acute Coronary Syndrome, Atrial Fibrillation, Ischemic Stroke; Ischemic Attack, Transient

Studies at this site

• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling